- Home
- GNTA vs LRE Comparison
GNTA vs LRE Comparison
Compare GNTA & LRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNTA
- LRE
- Stock Information
- Founded
- GNTA 2014
- LRE 2001
- Country
- GNTA Italy
- LRE Japan
- Employees
- GNTA N/A
- LRE N/A
- Industry
- GNTA Biotechnology: Biological Products (No Diagnostic Substances)
- LRE
- Sector
- GNTA Health Care
- LRE
- Exchange
- GNTA Nasdaq
- LRE Nasdaq
- Market Cap
- GNTA 81.2M
- LRE 17.6M
- IPO Year
- GNTA 2021
- LRE 2023
- Fundamental
- Price
- GNTA N/A
- LRE N/A
- Analyst Decision
- GNTA Strong Buy
- LRE
- Analyst Count
- GNTA 1
- LRE 0
- Target Price
- GNTA $25.00
- LRE N/A
- AVG Volume (30 Days)
- GNTA 29.4K
- LRE 14.8K
- Earning Date
- GNTA 01-01-0001
- LRE 01-01-0001
- Dividend Yield
- GNTA N/A
- LRE N/A
- EPS Growth
- GNTA N/A
- LRE N/A
- EPS
- GNTA N/A
- LRE N/A
- Revenue
- GNTA N/A
- LRE $110,330,328.00
- Revenue This Year
- GNTA N/A
- LRE N/A
- Revenue Next Year
- GNTA N/A
- LRE N/A
- P/E Ratio
- GNTA N/A
- LRE N/A
- Revenue Growth
- GNTA N/A
- LRE 8.82
- 52 Week Low
- GNTA $2.74
- LRE $1.10
- 52 Week High
- GNTA $7.28
- LRE $2.49
- Technical
- Relative Strength Index (RSI)
- GNTA 54.55
- LRE 57.65
- Support Level
- GNTA $2.74
- LRE $1.71
- Resistance Level
- GNTA $3.94
- LRE $2.11
- Average True Range (ATR)
- GNTA 0.29
- LRE 0.12
- MACD
- GNTA 0.08
- LRE -0.01
- Stochastic Oscillator
- GNTA 88.33
- LRE 34.69
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.
About LRE Lead Real Estate Co. Ltd
Lead Real Estate Co Ltd operates as a developer of luxury residential properties, including single-family homes and condominiums, across Tokyo, Kanagawa prefecture, and Sapporo. The company also operates hotels in Tokyo and leases apartment building units to individual customers in Japan and Dallas, Texas. Predominantly, its revenue is generated from developing and selling single-family homes and condominiums. The company's sole operating segment is real estate sales. Geographically, it derives revenue from Japan.